Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 3/20 | 0.52 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.44 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.44 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.42 |
| ▸ | APLNR | P35414 | 2/20 | 0.41 |
| ▸ | TLR2 | O60603 | 3/20 | 0.41 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.39 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.39 |
| ▸ | NMT2 | O60551 | 1/20 | 0.39 |
| ▸ | NMT1 | P30419 | 1/20 | 0.39 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1163474 | 1.00 | SLC6A5 (0.52) | SLC6A5SLC15A2ITGB3ITGA2BNOD1 | |
| SCHEMBL31138844 | 0.99 | SLC6A5 (0.50) | SLC6A5SLC15A2ITGB3ITGA2BNOD1 | |
| SCHEMBL29467847 | 0.97 | SLC6A5 (0.49) | SLC6A5SLC15A2ITGB3ITGA2BNOD1 | |
| SCHEMBL17844297 | 0.90 | SLC6A5 (0.52) | SLC6A5ITGB3ITGA2BNOD1APLNR | |
| SCHEMBL17844295 | 0.90 | SLC6A5 (0.52) | SLC6A5ITGB3ITGA2BNOD1APLNR | |
| SCHEMBL30716920 | 0.90 | SLC6A5 (0.52) | SLC6A5SLC15A2ITGB3ITGA2BNOD1 | |
| SCHEMBL30562642 | 0.90 | SLC6A5 (0.52) | SLC6A5SLC15A2ITGB3ITGA2BNOD1 | |
| SCHEMBL29941942 | 0.90 | SLC6A5 (0.52) | SLC6A5SLC15A2ITGB3ITGA2BNOD1 | |
| SCHEMBL29942005 | 0.89 | SLC6A5 (0.51) | SLC6A5SLC15A2ITGB3ITGA2BNOD1 | |
| SCHEMBL27605476 | 0.89 | SLC15A2 (0.47) | SLC6A5SLC15A2ITGB3ITGA2BTLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 538 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3506873-B1 | PERSONAL CARE GEL AND METHOD | COLGATE PALMOLIVE CO (US) | 2021-11-03 | — | — | EP | claimed |
| EP-3137039-B1 | PERSONAL CARE COMPOSITION FOR A KERATIN SUBSTRATE COMPRISING CONDITIONING AND/OR STYLING CATIONIC TETRA POLYMER | HERCULES LLC (US) | 2020-08-12 | — | — | EP | claimed |
| EP-2914239-B1 | COMPOSITION COMPRISING CONDITIONING AND/OR STYLING POLYMER | HERCULES LLC (US) | 2020-04-29 | — | — | EP | claimed |
| US-10610480-B2 | Personal care composition for a keratin substrate comprising conditioning, color protecting and styling polymer | ISP INVESTMENTS LLC (US) | 2020-04-07 | — | — | US | claimed |
| EP-3522859-A1 | PERSONAL CARE COMPOSITION FOR A KERATIN SUBSTRATE COMPRISING CONDITIONING, COLOR PROTECTING AND STYLING POLYMER | ISP Investments LLC (US) | 2019-08-14 | — | — | EP | claimed |
| US-20190209442-A1 | Personal Care Gel and Method | COLGATE-PALMOLIVE COMPANY (US) | 2019-07-11 | — | — | US | claimed |
| EP-3506873-A1 | PERSONAL CARE GEL AND METHOD | Colgate-Palmolive Company (US) | 2019-07-10 | — | — | EP | claimed |
| US-20190151224-A1 | PERSONAL CARE COMPOSITIONS COMPRISING COPOLYMERS OF CATIONIC MONOMERS AND ACRYLOYL LACTAM BASED MONOMERS, PROCESS FOR THE SAME AND METHOD OF USE | ISP INVESTMENTS LLC (US) | 2019-05-23 | — | — | US | claimed |
| US-20190099349-A1 | PERSONAL CARE COMPOSITION FOR A KERATIN SUBSTRATE COMPRISING CONDITIONING, COLOR PROTECTING AND STYLING POLYMER | ISP INVESTMENTS LLC (US) | 2019-04-04 | — | — | US | claimed |
| WO-2018056989-A1 | PERSONAL CARE GEL AND METHOD | COLGATE-PALMOLIVE COMPANY (US) | 2018-03-29 | — | — | WO | claimed |
| US-7459166-B2 | Cosmetic product containing mineral water for remineralizing and rejuvenating the skin | COTY B.V. (NL) | 2008-12-02 | — | — | US | claimed |
| US-20080213198-A1 | Cosmetic or Dermopharmaceutical Composition Comprising at Least one Udp Glucuronosyl Transferase (Ugt) Enzymes Inducer | SEDERMA SAS (FR) | 2008-09-04 | — | — | US | claimed |
| EP-1904020-A2 | NEW SLIMMING COSMETIC COMPOSITIONS | Sederma S.A.S. (FR) | 2008-04-02 | — | — | EP | claimed |
| EP-1633441-B1 | COSMETIC PRODUCT CONTAINING MINERAL WATER FOR REMINERALISING AND REJUVENATING THE SKIN | COTY BV (NL) | 2008-02-13 | — | — | EP | claimed |
| US-7235249-B2 | Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions | THE PROCTER & GAMBLE COMPANY (US) | 2007-06-26 | — | — | US | claimed |
| EP-1776161-A1 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE UDP GLUCURONOSYL TRANSFERASE (UGT) ENZYMES INDUCER | Sederma S.A.S. (FR) | 2007-04-25 | — | — | EP | claimed |
| US-20070086966-A1 | Cosmetic product containing mineral water for remineralising and rejuvenating the skin | JPMORGAN CHASE BANK, N.A. | 2007-04-19 | — | — | US | claimed |
| WO-2007010478-A2 | SLIMMING COSMETIC COMPOSITIONS | SEDERMA (FR) | 2007-01-25 | — | — | WO | claimed |
| WO-2005102266-A1 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE UDP GLUCURONOSYL TRANSFERASE (UGT) ENZYMES INDUCER | SEDERMA, SAS (FR) | 2005-11-03 | — | — | WO | claimed |
| US-6492326-B1 | CONTAINING A PENTAPEPTIDE | THE PROCTER & GAMBLE COMPANY | 2002-12-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080213198-A1 | Cosmetic or Dermopharmaceutical Composition Comprising at Least one Udp Glucuronosyl Transferase (Ugt) Enzymes Inducer | UGT1A1, UGT1A3, UGDH | SLC6A5 4076/4885SLC15A2 762/4885ITGB3 3287/4885 |
| US-20190209442-A1 | Personal Care Gel and Method | CUTA, GLMN, ISG15 | SLC6A5 3266/4885SLC15A2 1425/4885ITGB3 2628/4885 |
| US-20190151224-A1 | PERSONAL CARE COMPOSITIONS COMPRISING COPOLYMERS OF CATIONIC MONOMERS AND ACRYLOYL LACTAM BASED MONOMERS, PROCESS FOR THE SAME AND METHOD OF USE | AADAC, KRT18, AAAS | SLC6A5 3057/4885SLC15A2 3381/4885ITGB3 732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.